Evidence map›Paper›PMID 37097022›Full record

ReviewEFORT open reviews2023

The role of platelet-rich plasma in shoulder pathologies: a critical review of the literature.

Claudio Rosso, Mark E Morrey, Michael O Schär, Kushtrim Grezda, Swiss Orthopaedics Shoulder Elbow and Expert Group, Swiss Orthopaedics Shoulder and Elbow Expert Group †

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in EFORT open reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07659600 (Performance of Autologous Platelet-rich Plasma Injection for Tendon Regeneration in Partial Supraspinatus Tears), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07659600 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Performance of Autologous Platelet-rich Plasma Injection for Tendon Regeneration in Partial Supraspinatus Tears

TypeinterventionalSponsorUniversidade Nova de LisboaRan2026 to 2029Enrolled100ConditionsPartial Supraspinatus Tear, Rotator Cuff Tears (RCTs), Rotator Cuff InjuryArmsPlatelet-Rich Plasma (PRP) Injections
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Claudio RossoARTHRO Medics, Shoulder and Elbow Center, Basel, Switzerland.
Mark E MorreySwiss Orthopaedics, Grandvaux, Switzerland.
Michael O SchärSwiss Orthopaedics, Grandvaux, Switzerland.
Kushtrim GrezdaARTHRO Medics, Shoulder and Elbow Center, Basel, Switzerland.
Swiss Orthopaedics Shoulder Elbow and Expert Group
Swiss Orthopaedics Shoulder and Elbow Expert Group †
Swiss Paediatric Oncology Group · CHUniversity of Basel · CHSwissmedic · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelet-rich plasma (PRP) is a revolutionary treatment that harnesses the regenerative power of the body's own platelets to promote healing and tissue regeneration. While PRP therapy has emerged as a promising option for augmenting biologic healing in the shoulder, the complexity of shoulder disorders makes it difficult to draw definitive conclusions about the efficacy of PRP across different conditions and stages of disease. Our comprehensive review of twenty-four studies highlights the current state of PRP therapy in shoulder pathologies, revealing a wide variety of number of patients, control groups and results. Despite these challenges, the regenerative potential of PRP therapy is moderate in some conditions, with numerous studies demonstrating the positive effects. In conclusion, the authors of this study recommend the use of PRP therapy for adhesive capsulitis and rotator cuff repair of medium to large tears. However, they do not recommend the use of PRP for subacromial impingement or rotator cuff tears. It is up to the clinician's discretion to decide whether PRP therapy is appropriate for individual cases. However, there is still insufficient evidence to support the inclusion of PRP therapy in treatment protocols for other shoulder disorders. Therefore, further research is needed to fully explore the potential of PRP therapy in the treatment of various shoulder conditions.

Indexed as

Platelet-rich plasma (PRP)reviewshoulder pathologies

Identifiers

PMID37097022
PMCPMC10155124
OpenAlexW4366993058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.